Responsiveness of the National Eye Institute Visual Function Questionnaire-25 to Visual Acuity Gains in Patients with Diabetic Macular Edema

PURPOSE To evaluate the responsiveness of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in patients with diabetic macular edema using data from the RIDE and RISE trials. METHODS Patients were randomized to monthly intravitreal ranibizumab 0.3 mg, 0.5 mg, or sham injections for 2 years. The NEI VFQ-25 was administered at baseline… CONTINUE READING